Lyme disease Archives -

Pfizer has acquired an 8.1% stake in French vaccines developer Valneva at a cost of €90.5 million (around

Pfizer takes stake in French Lyme disease jab partner Valneva

https://pharmaphorum.com/news/pfizer-takes-stake-in-french-lyme-disease-jab-partner-valneva/

There’s only one vaccine candidate for tick-borne infection Lyme disease in clinical development – Valneva and Pfizer’s VLA15

Readout sets up phase 3 for Valneva/Pfizer’s Lyme disease jab

https://pharmaphorum.com/news/readout-sets-up-phase-3-for-valneva-pfizers-lyme-disease-jab/

Prospects for Valneva’s COVID-19 vaccine are up in the air, but another candidate partnered with Pfizer looks increasingly

Booster data backs Pfizer, Valneva Lyme disease vaccine

https://pharmaphorum.com/news/booster-data-backs-pfizer-valneva-lyme-disease-vaccine/

Valneva has said it plans to accelerate research into its Lyme disease vaccine candidate VLA15, bringing forward a

Valneva accelerates Lyme disease vaccine R&D project with Pfizer

https://pharmaphorum.com/news/valneva-accelerates-lyme-disease-vaccine-rd-project-with-pfizer/

Lyme disease